Use of Markov Chain Monte Carlo Analysis with a Physiologically‐Based Pharmacokinetic Model of Methylmercury to Estimate Exposures in U.S. Women of Childbearing Age
- 1 August 2007
- journal article
- Published by Wiley in Risk Analysis
- Vol. 27 (4), 947-959
- https://doi.org/10.1111/j.1539-6924.2007.00934.x
Abstract
A Bayesian approach, implemented using Markov Chain Monte Carlo (MCMC) analysis, was applied with a physiologically-based pharmacokinetic (PBPK) model of methylmercury (MeHg) to evaluate the variability of MeHg exposure in women of childbearing age in the U.S. population. The analysis made use of the newly available National Health and Nutrition Survey (NHANES) blood and hair mercury concentration data for women of age 16-49 years (sample size, 1,582). Bayesian analysis was performed to estimate the population variability in MeHg exposure (daily ingestion rate) implied by the variation in blood and hair concentrations of mercury in the NHANES database. The measured variability in the NHANES blood and hair data represents the result of a process that includes interindividual variation in exposure to MeHg and interindividual variation in the pharmacokinetics (distribution, clearance) of MeHg. The PBPK model includes a number of pharmacokinetic parameters (e.g., tissue volumes, partition coefficients, rate constants for metabolism and elimination) that can vary from individual to individual within the subpopulation of interest. Using MCMC analysis, it was possible to combine prior distributions of the PBPK model parameters with the NHANES blood and hair data, as well as with kinetic data from controlled human exposures to MeHg, to derive posterior distributions that refine the estimates of both the population exposure distribution and the pharmacokinetic parameters. In general, based on the populations surveyed by NHANES, the results of the MCMC analysis indicate that a small fraction, less than 1%, of the U.S. population of women of childbearing age may have mercury exposures greater than the EPA RfD for MeHg of 0.1 microg/kg/day, and that there are few, if any, exposures greater than the ATSDR MRL of 0.3 microg/kg/day. The analysis also indicates that typical exposures may be greater than previously estimated from food consumption surveys, but that the variability in exposure within the population of U.S. women of childbearing age may be less than previously assumed.Keywords
This publication has 18 references indexed in Scilit:
- An Exposure Assessment for Methylmercury from Seafood for Consumers in the United StatesRisk Analysis, 2002
- Determination of a site-specific reference dose for methylmercury for fish-eating populationsToxicology and Industrial Health, 2000
- Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior DistributionsJournal of the American Statistical Association, 1996
- Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in a large epidemiological studyWater, Air, & Soil Pollution, 1995
- Minamata Disease: Methylmercury Poisoning in Japan Caused by Environmental PollutionCritical Reviews in Toxicology, 1995
- Physiological Model for the Pharmacokinetics of Methyl Mercury in the Growing RatToxicology and Applied Pharmacology, 1993
- Impact of Maternal Seafood Diet on Fetal Exposure to Mercury, Selenium, and LeadArchives of environmental health, 1992
- Elevation of Mercury in Human Blood from Controlled Chronic Ingestion of Methylmercury in FishHuman Toxicology, 1984
- Methylmercury Poisoning in IraqScience, 1973
- Studies on Humans Exposed to Methyl Mercury Through Fish ConsumptionArchives of environmental health, 1972